Phase 1b/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects With Previously Treated Soft-Tissue Sarcomas (STS) With Pulmonary Metastases
Clinical trial NCT05518526 · UNKNOWN
Trial details
- NCT number
- NCT05518526
- Sponsor
- Maria Sklodowska-Curie National Research Institute of Oncology
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-23
- Primary completion
- 2025-08-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.